Mucopolysaccharidoses

61
Mucopolysaccharidoses Prof. Dr. Saad S Al Ani Senior Pediatric Consultant Head of Pediatric Department Khorfakkan Hospital Sharjah ,UAE [email protected]

Transcript of Mucopolysaccharidoses

Mucopolysaccharidoses

Prof. Dr. Saad S Al Ani

Senior Pediatric Consultant

Head of Pediatric Department

Khorfakkan Hospital

Sharjah ,UAE

[email protected]

Mucopolysaccharidoses

Hereditary, progressive diseases caused by

mutations of genes coding for lysosomal

enzymes needed to degrade glycosaminoglycans

(GAGs) (acid mucopolysaccharides).

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital2

Glycosaminoglycan(GAG)

A long-chain complex

carbohydrate composed

of:

1. Uronic acids

2. Amino sugars

3. Neutral sugars.

www.mun.ca

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital3

Glycosaminoglycans(GAGs)

The major GAGs are:

1. Chondroitin -4- sulfate

2. Chondroitin -6- sulfate

3. Heparan sulfate

4. Dermatan sulfate

5. Keratan sulfate

6. Hyaluronan

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital4

Glycosaminoglycans (GAGs) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital5

Major constituents of the ground substance of connective

tissue, as well as nuclear and cell membranes

Proteoglycans degradation

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital6

www.glycoforum.gr.jp

Proteoglycans

Protein coreProteolytic

Stepwise

degradation GAG moiety

Proteoglycans degradation disturbance

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital7

Absent or grossly reduced activity

of mutated lysosomal enzymes

Proteoglycans

Glycosaminoglycans (GAGs) Intralysosomal

Proteoglycans degradation disturbance(cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital8

printablecolouringpages.co.uk

Distended

lysosomes

cell

function

Characteristic pattern of clinical, radiologic, and

biochemical abnormalities

Specific diseases can be recognized that evolve from the

intracellular accumulation of different degradation products

Rule of fingers

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital9

Heparan sulfate(impaired degradation)

Mental

deficiency

Dermatan sulfate,

Chondroitin

sulfates,

Keratan sulfate

(impaired degradation)

Mesenchymal

abnormalities

Mucopolysaccharidoses

Mucopolysaccharidoses are autosomal recessive

disorders, with the exception of Hunter disease,

which is X- linked recessive.

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital10

Mucopolysaccharidoses (cont.)

Overall frequency is between

3.5/100,000 and 4.5/100,000

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital11

teamsanfilippo.org

http://dxline.info/

Diseases /hurler-

syndrome

flipper.diff.org

The most common subtype is

Sanfilippo disease (MPS-III)

followed by Hurler disease

( MPS-I )

And Hunter disease (MPS II

Sanfilippo Syndrome(MPSIII)

A deficiency in one of the enzymes required to

break down glycosaminoglycan heparan sulfate

(found on the cell surface glycoproteins and

also in extra-cellular matrix)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital12

http://www.primehealthchannel.com/sanfilippo-syndrome

A rare form of lysosomal storage disease

Inherited in an autosomal recessive pattern

www.primehealthchannel.com

Sanfilippo Syndrome (cont.)

Deficiency in one of the four enzymes:

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital14

1. Heparan N- sulfatase (type A)

Sanfilippo Syndrome (cont.)

2.Alpha-N- acetylglucosaminidase (type B)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital15

Sanfilippo Syndrome (cont.)

3. Acetyl -Co Alpha- glucosaminide

acetyltransferase (type C)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital16

Sanfilippo Syndrome (cont.)

4.N- acetylglucosamine 6-sulfatase (type D)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital17

Sanfilippo Syndrome (cont.)

Patients are characterized by slowly progressive,

severe CNS involvement with mild somatic

disease

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital18

Onset of clinical features usually occurs between

2 and 6 yr in a child who previously appeared

normal.

Sanfilippo Syndrome (cont.)

Presenting features include:

– Delayed development

– Hyperactivity with aggressive behavior

– Coarse hair

– Hirsutism

– Sleep disorders

– Mild hepatosplenomegaly

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital19

articleactive.com

Sanfilippo Syndrome (cont.)

Severe neurologic deterioration occurs in mostpatients by 6-10 yr of age, accompanied by rapiddeterioration of social and adaptive skills

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital20

ellendelbloggolo.blogspot.com

Sanfilippo Syndrome (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital21

elle

ndel

blo

ggolo

.blo

gsp

ot.

comSevere behavior problems such as:

- Sleep disturbance

- Uncontrolled hyperactivity

- Temper tantrums

- Destructive behavior

- Physical aggression

are common

Sanfilippo Syndrome (cont.)

Delays in diagnosis of MPS III are commondue to :

- Mild physical features

- Hyperactivity

- Slowly progressive neurologic disease

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital22

rareshare.org

MPS 1

MPS I is caused by mutations of the IUA

gene on chromosome 4p16.3 encoding α-L-

iduronidase

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital23

www.patienthelp.org

MPS1 (cont.)

Deficiency of α-L- iduronidase results in a

broad clinical spectrum, from severe Hurler

disease to mild Scheie diseases

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital24

www.patienthelp.org

Hurler Disease (MPS I)

This is a severe form of MPS I ,and it isprogressive disorder with multiple organ andtissue involvement that results in prematuredeath, usually by 10 yr of age

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital25

www.eyecalcs.com

Hurler Disease (cont.)

An infant with Hurler syndrome appears

normal at birth, but inguinal hernias are often

present

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital26

www.eyecalcs.com

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital27

www.eyecalcs.com

Most patients have:

• Recurrent upper respiratory tract and

ear infections

• Noisy breathing

• Persistent copious nasal discharge

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital28

www.eyecalcs.com

Cardiac involvement include:

• Valvular heart disease:

Mitral and Aortic valves incompetence

• Coronary artery narrowing

Obstructive airway disease, notably during sleep, may necessitate tracheotomy.

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital29

www.eyecalcs.com

Most children with Hurler syndrome acquire

social but only limited language skills

because of :

• Developmental delay

• Combined conductive and neurosensory

hearing loss

• An enlarged tongue

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital30

www.eyecalcs.com

Headache and sleep disturbance due to:

Progressive ventricular enlargement with

increased intracranial pressure caused by

communicating hydrocephalus

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital31

www.eyecalcs.com

Common eye involvement include:

• Corneal clouding

• Glaucoma

• Retinal degeneration

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital32

www.eyecalcs.com

Skeletal abnormalities include:

• Enlarged, coarsely trabeculated diaphyses

of the long bones

• Irregular metaphyses and epiphyses

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital33

www.eyecalcs.com

Radio-graphs show a

characteristic skeletal

dysplasia known as

dysostosis multiplex

The earliest radiographic

signs are thick ribs and

ovoid vertebral bodies

http://www.keywordpicture.com/keyword/arthrogryposis%20multiplex

http://www.maroteaux-lamy.com/Turkish/HCP/Bones.aspx

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital34

ww

w.e

yec

alcs

.com

With progression of the disease macrocephaly

develops, with:

• Thickened calvarium

• Premature closure of lambdoid and

sagittal sutures

• Shallow orbits

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital35

ww

w.e

yec

alcs

.com

Cont.

• Enlarged J-shaped sella

• Abnormal spacing of teeth with

dentigenous cysts

Hurler Disease (cont.) Diagnosis

Usually made between 6 and 24 mo of age

with evidence of:

– Hepatosplenomegaly

– Coarse facial features

– Corneal clouding

– Large tongue

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital36

ww

w.e

yec

alcs

.com

nlm.nih.gov

Hurler Disease (cont.) Diagnosis

-Prominent forehead

– Joint stiffness

– Short stature

– Skeletal dysplasia

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital37

ww

w.e

yec

alcs

.com

http://www.scripps.org/articles/99-frontal-bossing

http://www.nemours.org/service/medical/skeletal-dysplasia

http://doctorsgates.blogspot.ae

http://emedicine.medscape.com/article/951148-overview

Hurler Disease (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital38

www.eyecalcs.com

Common causes of death:

• Obstructive airway disease

• Respiratory infection

• Cardiac complications

Hunter disease (MPS II)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital39

Is an X-linked disorder caused by the

deficiency of iduronate-2-sulfatase (IDS)

flipper.diff.org

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital40

flipper.diff.org

The gene encoding IDS is mapped to Xq28.

Point mutations of the IDS gene have been

detected in about 80% of patients with MPS II

Hunter disease manifests almost exclusively in

males. it has been observed in a few females

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital42

flipper.diff.org

Patients with severe MPS II have features

similar to those of Hurler disease except for:

• Lack of corneal clouding

• Slower progression of:

Somatic and Central nervous system

(CNS) deterioration

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital43

flipper.diff.org

Clinical manifestations:

• Coarse facial features

• Short stature

• Dysostosis multiplex

• Joint stiffness

• Mental retardation manifest between

2 and 4 yr of age.

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital44

flipper.diff.org

The following may present

• Grouped skin papules

• Extensive Mongolian spots

• Chronic diarrhea

• Communicating hydrocephalus and

spastic paraplegia

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital45

Patients with the mild form have:

• Prolonged life span

• Minimal CNS involvement

• Slow progression of somatic deterioration

with preservation of intelligence in adult

life

flipper.diff.org

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital46

In severely affected patients:

• Extensive, slowly progressive neurologic

involvement

• Death, which usually occurs between 10

and 15 yr of age.

flipper.diff.org

Hunter disease (MPS II) (cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital47

In both the mild and severe forms:

• Airway involvement

• Valvular cardiac disease

• Hearing impairment

• Carpal tunnel syndrome

• Joint stiffness

Are common and can result in significant

loss of function

flipper.diff.org

Diagnosis of MPS

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital48

Any individual who is suspected of an MPS

disorder based on:

• Clinical features

• Radiographic results

• Urinary GAG screening tests

Should have a definitive diagnosis established

by enzyme assay

Differential diagnosis

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital49

1.Mucolipidoses

2.Oligosaccharidoses

In these conditions, the urinary excretion of

GAGs is not elevated

3. Neurodegenerative and dwarfing conditions

Mucopolysaccharidoses can be differentiate from

them by the present of:• Hurler- like facial features

• Joint contractures

• Dysostosis multiplex

• Elevated urinary GAG excretion

Treatment of MPS

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital50

• Hematopoietic stem cell transplantation

results in significant clinical improvement of

somatic disease in MPS I, II, and VI

• Enzyme replacement using recombinant

enzymes is approved for patients with MPS I,

MPS II, and MPS VI.

Hematopoietic stem cell transplantation

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital51

Clinical effects include :

• Increased life expectancy

• Resolution or improvement of growth

failure

• Upper airway obstruction

• Hepatosplenomegaly

• Joint stiffness

• Facial appearance

Hematopoietic stem cell transplantation (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital52

• Pebbly skin changes

• Obstructive sleep apnea

• Heart disease

• Communicating hydrocephalus

• Hearing loss

Hematopoietic stem cell transplantation (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital53

Enzyme activity in serum and urinary GAG

excretion is normalized

Transplantation prevents neurocognitive

degeneration

Hematopoietic stem cell transplantation (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital54

Transplantation does not correct :

• Existent cerebral damage

• Skeletal and ocular anomalies

Enzyme replacement

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital55

-It reduces :

• Organomegaly

• Number of episodes of sleep apnea

• Urinary GAG excretion

Enzyme replacement (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital56

- It ameliorates :

• rate of growth

• joint mobility

• Physical endurance.

Enzyme replacement (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital57

-The enzymes do not:

• Cross the blood-brain barrier

• Prevent deterioration of neurocognitive

involvement.

-This therapy is the domain for patients with

mild central nervous involvement

Prevention

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital58

• Primary prevention

Through genetic counseling

• Tertiary prevention

To avoid or treat complications remains the

mainstay of supportive pediatric care

Prevention (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital59

Multidisciplinary attention to:• Respiratory and cardiovascular complications

• Hearing loss

• Carpal tunnel syndrome

• Spinal cord compression

• Hydrocephalus, and other problems

Can greatly improve the quality of life for

patients and their families

Prevention (Cont.)

3/1/2015Mucopolysaccharidoses

Prof.Dr.Saad S Al Ani Khorfakkan Hospital60

The progressive nature of clinical involvement

in MPS patients dictates the need for specialized

and coordinated evaluation